e-learning
resources
ERJ
2013
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The use of inhaled corticosteroids and the risk of adrenal insufficiency
Francesco Lapi, Abbas Kezouh, Samy Suissa, Pierre Ernst
Source:
Eur Respir J 2013; 42: 79-86
Journal Issue:
July
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Francesco Lapi, Abbas Kezouh, Samy Suissa, Pierre Ernst. The use of inhaled corticosteroids and the risk of adrenal insufficiency. Eur Respir J 2013; 42: 79-86
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Getting risks right on inhaled corticosteroids and adrenal insufficiency
Source: Eur Respir J 2013; 42: 9-11
Year: 2013
Low risk of adrenal dysfunction in children with severe asthma treated with high-dose inhaled glucocorticoids
Source: Eur Respir J 2005; 26: Suppl. 49, 161s
Year: 2005
Adrenal suppression in bronchiectasis and the impact of inhaled corticosteroids
Source: Eur Respir J 2008; 32: 1047-1052
Year: 2008
Adrenal suppression in children using inhaled corticosteroids: neither recommended nor presribed doses identify those at risk
Source: Annual Congress 2004 - New aspects of drug therapy in paediatric asthma
Year: 2004
Adrenal insufficiency in asthma treated with high/low systemic corticosteroids in the past and in those who sucessfully discontinued systemic corticosteroids after treatment with omalizmab.
Source: International Congress 2017 – Management of asthma in different situations
Year: 2017
Inhaled corticosteroids and adrenal insufficiency: a case-control study
Source: Eur Respir J 2005; 26: Suppl. 49, 220s
Year: 2005
Low-dose inhaled and nasal corticosteroid use and the risk of cataracts
Source: Eur Respir J 2006; 27: 1168-1174
Year: 2006
Adrenal crisis and hypercorticism induced by inhaled corticosteroids
Source: Eur Respir J 2006; 28: Suppl. 50, 665s
Year: 2006
Adrenal function with low acth doses in asthmatic children with inhaled corticosteroids
Source: Annual Congress 2009 - Asthma and comorbid conditions
Year: 2009
Inhaled corticosteroids and the risk of a first exacerbation in COPD patients
Source: Eur Respir J 2004; 23: 692-697
Year: 2004
Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids
Source: Breathe 2010; 6: 365
Year: 2010
Impact of inhaled corticosteroids in patients with cardiovascular disease
Source: Eur Respir Monogr 2020; 88: 251-263
Year: 2020
An economic evaluation of adding inhaled corticosteroids to systemic corticosteroids for treating acute asthma exacerbations
Source: International Congress 2019 – Severe acute asthma and troublesome wheezing
Year: 2019
Adrenal function improvement of most asthmatic children on inhaled corticosteroids
Source: Eur Respir J 2006; 28: Suppl. 50, 260s
Year: 2006
Rationale for use of inhaled steroids in children with bronchiectasis
Source: International Congress 2019 – Insights into paediatric bronchology
Year: 2019
Combination therapy of inhaled corticosteroids and long-acting beta
2
-agonists may be associated with risk reduction of lung cancer in COPD patients who quit smoking
Source: Eur Respir J 2006; 28: Suppl. 50, 454s
Year: 2006
A low-dose (1.0 mcg) rapid ACTH test and adrenal function in adult patients with bronchial asthma treated with inhaled corticosteroids
Source: Eur Respir J 2007; 30: Suppl. 51, 69s
Year: 2007
Estimation of risk of osteoporosis based on inhaled and oral corticosteroids
Source: Eur Respir J 2002; 20: Suppl. 38, 409s
Year: 2002
Inhaled corticosteroids and hospitalisation due to exacerbation of COPD
Source: Eur Respir J 2003; 22: 286-289
Year: 2003
Concomitant use of low-dose inhaled corticosteroids and a long-acting bronchodilatator visavi doubling the dose of inhaled corticosterod in asthma patients
Source: Eur Respir J 2001; 18: Suppl. 33, 98s
Year: 2001
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept